Anna Zychlinsky Scharff
- Co-authors
- Karsten RuscherUlrich DirnaglAndreas MeiselKonstantin PrassKrisztian KapinyaI. V. VictorovDirk MegowН. К. Исаев
- Topics
- Bladder and Urothelial Cancer Treatments (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Journals
- StrokeJournal of Cerebral Blood Flow & MetabolismThe Journal of Heart and Lung Transplantation
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Anna Zychlinsky Scharff
15 papers receiving 681 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 158
- Oncology 128
- Epidemiology 127
- Cancer Research 118
- Hematology 100
Countries citing papers authored by Anna Zychlinsky Scharff
This map shows the geographic impact of Anna Zychlinsky Scharff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zychlinsky Scharff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zychlinsky Scharff more than expected).
Fields of papers citing papers by Anna Zychlinsky Scharff
This network shows the impact of papers produced by Anna Zychlinsky Scharff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zychlinsky Scharff. The network helps show where Anna Zychlinsky Scharff may publish in the future.
Co-authorship network of co-authors of Anna Zychlinsky Scharff
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zychlinsky Scharff. A scholar is included among the top collaborators of Anna Zychlinsky Scharff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zychlinsky Scharff. Anna Zychlinsky Scharff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 25 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 133 | |
| 10 | 70 | |
| 11 | 21 | |
| 12 | 6 | |
| 13 | 238 | |
| 14 | 170 | |
| 15 | Kanamycin serum half-life and renal function: age and sex. | 4 |
| 16 | Correlation between renal function and serum half-life of kanamycin and its application to dosage adjustment. | 5 |
About Anna Zychlinsky Scharff
Anna Zychlinsky Scharff is a scholar working on Health, Pharmacy and Anesthesiology and Pain Medicine, having authored 16 papers that have together received 694 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Developmental Neuroscience (48 citations), Neurology (81 citations) and Hematology (100 citations). Anna Zychlinsky Scharff has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Karsten Ruscher, Ulrich Dirnagl, Andreas Meisel, Konstantin Prass, Krisztian Kapinya, I. V. Victorov, Dirk Megow, Н. К. Исаев, Josef Priller and Matthew L. Albert. Their work appears in journals such as Stroke, Journal of Cerebral Blood Flow & Metabolism and The Journal of Heart and Lung Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.